Items where authors include "Graham, J."

Article

Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. eClinicalMedicine, 81. 103080. ISSN 2589-5370

Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642

Sandercock, P., Darbyshire, J., DeMets, D. et al. (2050 more authors) (2024) Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Nature Communications, 15. 924. ISSN 2041-1723

Abani, O., Abbas, A., Abbas, F. et al. (7989 more authors) (2023) Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Diabetes & Endocrinology, 11 (12). pp. 905-914. ISSN 2213-8587

Abani, O., Abbas, A., Abbas, F. et al. (8104 more authors) (2023) Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 401 (10387). pp. 1499-1507. ISSN 0140-6736

Brown, J.E. orcid.org/0000-0003-4960-3032, Royle, K.-L., Gregory, W. et al. (96 more authors) (2023) Temporary treatment cessation versus continuation of first-line tyrosine kinase inhibitor in patients with advanced clear cell renal cell carcinoma (STAR): an open-label, non-inferiority, randomised, controlled, phase 2/3 trial. The Lancet Oncology, 24 (3). pp. 213-227. ISSN 1470-2045

Dearnaley, D., Hinder, V., Hijab, A. et al. (25 more authors) (2022) Observation versus screening spinal MRI and pre-emptive treatment for spinal cord compression in patients with castration-resistant prostate cancer and spinal metastases in the UK (PROMPTS): an open-label, randomised, controlled, phase 3 trial. The Lancet Oncology, 23 (4). pp. 501-513. ISSN 1470-2045

Gore, M.L., Braszak, P., Brown, J. et al. (14 more authors) (2019) Transnational environmental crime threatens sustainable development. Nature Sustainability, 2 (9). pp. 784-786.

Kearns, B. orcid.org/0000-0001-7730-668X, Pandor, A. orcid.org/0000-0003-2552-5260, Stevenson, M. orcid.org/0000-0002-3099-9877 et al. (5 more authors) (2016) Cabazitaxel for Hormone-Relapsed Metastatic Prostate Cancer Previously Treated With a Docetaxel-Containing Regimen: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. Pharmacoeconomics. ISSN 1170-7690

Graham, J., McBride, D., Stull, D. et al. (7 more authors) (2016) Cost Utility of Omalizumab Compared with Standard of Care for the Treatment of Chronic Spontaneous Urticaria. Pharmacoeconomics, 34 (8). pp. 815-827. ISSN 1170-7690

Toner, J., McAnallen, C., Proops, D. et al. (33 more authors) (2004) Criteria of candidacy for unilateral cochlear implantation in postlingually deafened adults I: Theory and measures of effectiveness. Ear & Hearing, 25 (4). pp. 310-335. ISSN 0196-0202

Vasey, P.A., Atkinson, R., Coleman, R. orcid.org/0000-0002-4275-1043 et al. (9 more authors) (2001) Docetaxel-carboplatin as first line chemotherapy for epithelial ovarian cancer. British Journal of Cancer, 84 (2). pp. 170-178. ISSN 0007-0920

Proceedings Paper

Gallardo Ceron, F., West, J., Burke, I. et al. (2 more authors) (2023) Cluster Analysis for Hydrogeological Units Identification and Characterisation in Glaciofluvial Sediments. In: Proceedings of Fifth EAGE Conference on Petroleum Geostatistics. Fifth EAGE Conference on Petroleum Geostatistics, 27-30 Nov 2023, Porto, Portugal. European Association of Geoscientists & Engineers .